{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:13:25Z","timestamp":1790262805530,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"28","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["IM\/HK-1\/07\/8\/6"],"award-info":[{"award-number":["IM\/HK-1\/07\/8\/6"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.vaccine.2017.05.036","type":"journal-article","created":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T23:01:34Z","timestamp":1495494094000},"page":"3534-3547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Retinoic acid pre-treatment down regulates V. cholerae outer membrane vesicles induced acute inflammation and enhances mucosal immunity"],"prefix":"10.1016","volume":"35","author":[{"given":"Ritam","family":"Sinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debaki Ranjan","family":"Howlader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atri","family":"Ta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soma","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santasabuj","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemanta","family":"Koley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2017.05.036_b0005","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1086\/341206","article-title":"Epidemic and endemic cholera trends over a 33-year period in Bangladesh","volume":"186","author":"Longini","year":"2002","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2017.05.036_b0010","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1017\/S0950268809990550","article-title":"El Tor cholera with severe disease a new threat to Asia and beyond","volume":"138","author":"Siddique","year":"2010","journal-title":"Epidemiol Infect"},{"issue":"21","key":"10.1016\/j.vaccine.2017.05.036_b0015","doi-asserted-by":"crossref","first-page":"8767","DOI":"10.1073\/pnas.1019712108","article-title":"Estimating the reproductive numbers for the 2008\u20132009 cholera outbreaks in Zimbabwe","volume":"108","author":"Mukandavire","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9773","key":"10.1016\/j.vaccine.2017.05.036_b0020","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0140-6736(11)60273-0","article-title":"Transmission dynamics and control of cholera in Haiti an epidemic model","volume":"377","author":"Andrews","year":"2011","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2017.05.036_b0025","doi-asserted-by":"crossref","first-page":"973","DOI":"10.4269\/ajtmh.2006.75.973","article-title":"Review of reported cholera outbreaks worldwide, 1995\u20132005","volume":"75","author":"Griffith","year":"2006","journal-title":"Am J Trop Med Hyg"},{"issue":"9","key":"10.1016\/j.vaccine.2017.05.036_b0030","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1128\/CVI.00378-14","article-title":"Critical analysis of compositions and protective efficacies of oral killed cholera vaccines","volume":"21","author":"Kabir","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"27 Suppl 2","key":"10.1016\/j.vaccine.2017.05.036_b0035","doi-asserted-by":"crossref","first-page":"B3","DOI":"10.1016\/j.vaccine.2009.04.071","article-title":"Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis","volume":"24","author":"Holst","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.036_b0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1574-695X.2010.00692.x","article-title":"Immunogenicity and protective efficacy of Vibrio cholerae outer membrane vesicles in rabbit model","volume":"60","author":"Roy","year":"2010","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.036_b0045","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1128\/IAI.01139-08","article-title":"Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera","volume":"77","author":"Schild","year":"2009","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2017.05.036_b0050","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/infdis\/jir756","article-title":"Immunization of mice with Vibrio cholerae outer-membrane vesicles protects against hyperinfectious challenge and blocks transmission","volume":"205","author":"Bishop","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.05.036_b0055","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1128\/IAI.01382-12","article-title":"Lipopolysaccharide modifications of a cholera vaccine candidate based on outer membrane vesicles reduce endotoxicity and reveal the major protective antigen","volume":"81","author":"Leitner","year":"2013","journal-title":"Infect Immun"},{"issue":"15","key":"10.1016\/j.vaccine.2017.05.036_b0060","doi-asserted-by":"crossref","first-page":"E1548","DOI":"10.1073\/pnas.1403683111","article-title":"Proteomic analysis of Vibrio cholerae outer membrane vesicles","volume":"111","author":"Altindis","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.vaccine.2017.05.036_b0065","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri3837","article-title":"Immune modulation by bacterial outer membranevesicles","volume":"15","author":"Kaparakis-Liaskos","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"38","key":"10.1016\/j.vaccine.2017.05.036_b0070","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.1016\/j.vaccine.2015.05.014","article-title":"Altered host immune responses to membrane vesicles from Salmonella and Gram-negative pathogens","volume":"33","author":"Laughlin","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2017.05.036_b0075","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1172\/JCI44261","article-title":"Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice","volume":"121","author":"Prados-Rosales","year":"2011","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.vaccine.2017.05.036_b0080","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1128\/IAI.01365-15","article-title":"Cytotoxic and inflammatory responses induced by outer membrane vesicle-associated biologically active proteases from vibrio cholerae","volume":"84","author":"Mondal","year":"2016","journal-title":"Infect Immun"},{"issue":"1671","key":"10.1016\/j.vaccine.2017.05.036_b0085","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2014.0145","article-title":"Potential for use of retinoic acid as an oral vaccine adjuvant","volume":"370","author":"Mwanza-Lisulo","year":"2015","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2017.05.036_b0090","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/jlb.55.3.336","article-title":"Inhibition by all-trans-retinoic acid of tumor necrosis factor and nitric oxide production by peritoneal macrophages","volume":"55","author":"Mehta","year":"1994","journal-title":"J Leukoc Biol"},{"issue":"9","key":"10.1016\/j.vaccine.2017.05.036_b0095","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0192-0561(00)00032-1","article-title":"Effect of all-trans-retinoic acid on cytokine production in a murine macrophage cell line","volume":"22","author":"Mathew","year":"2000","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.vaccine.2017.05.036_b0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2011.07.002","article-title":"The role of retinoic acid in tolerance and immunity","volume":"35","author":"Hall","year":"2011","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.vaccine.2017.05.036_b0105","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.imbio.2016.01.011","article-title":"Retinoic acid decreases the severity of Salmonella enterica serovar Typhimurium mediated gastroenteritis in a mouse model","volume":"221","author":"Sinha","year":"2016","journal-title":"Immunobiology"},{"issue":"3","key":"10.1016\/j.vaccine.2017.05.036_b0110","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.micinf.2014.10.011","article-title":"Pentavalent outer membrane vesicles of Vibrio cholerae induce adaptive immune response and protective efficacy in both adult and passive suckling mice models","volume":"17","author":"Sinha","year":"2015","journal-title":"Microbes Infect"},{"issue":"10","key":"10.1016\/j.vaccine.2017.05.036_b0115","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1128\/CVI.00282-09","article-title":"Toll-like receptor 3 ligand and retinoic acid enhance germinal center formation and increase the tetanus toxoid vaccine response","volume":"16","author":"Ma","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"38","key":"10.1016\/j.vaccine.2017.05.036_b0120","doi-asserted-by":"crossref","first-page":"13556","DOI":"10.1073\/pnas.0506438102","article-title":"The anti-tetanus immune response of neonatal mice is augmented by retinoic acid combined with polyriboinosinic:polyribocytidylic acid","volume":"102","author":"Ma","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.vaccine.2017.05.036_b0125","doi-asserted-by":"crossref","first-page":"e7352","DOI":"10.1371\/journal.pone.0007352","article-title":"Successful small intestine colonization of adult mice by Vibrio cholerae requires ketamine anesthesia and accessory toxins","volume":"4","author":"Olivier","year":"2009","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.vaccine.2017.05.036_b0130","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.molimm.2006.04.007","article-title":"Porin of Shigella dysenteriaeactivates mouse peritoneal macrophage through Toll-like receptors 2 and 6 to induce polarized type I response","volume":"44","author":"Biswas","year":"2007","journal-title":"Mol Immunol"},{"issue":"20","key":"10.1016\/j.vaccine.2017.05.036_b0135","doi-asserted-by":"crossref","first-page":"12968","DOI":"10.1074\/jbc.272.20.12968","article-title":"Activation of HIV-1 long terminal repeat transcription and virus replication via NF-kappa B-dependent and -independent pathways by potent phosphotyrosine phosphatase inhibitors, the peroxovanadium compounds","volume":"272","author":"Barbeau","year":"1997","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.vaccine.2017.05.036_b0140","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1172\/JCI20762","article-title":"Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like syndromes","volume":"113","author":"Meng","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2017.05.036_b0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-bioeng-071811-150054","article-title":"Mucosal vaccine design and delivery","volume":"14","author":"Woodrow","year":"2012","journal-title":"Annu Rev Biomed Eng"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.036_b0150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0264-410X(92)90021-B","article-title":"The mucosal immune system from fundamental concepts to vaccine development","volume":"10","author":"McGhee","year":"1992","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2017.05.036_b0155","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/intimm\/dxu063","article-title":"Challenges in mucosal vaccines for the control of infectious diseases","volume":"26","author":"Azegami","year":"2014","journal-title":"Int Immunol."},{"issue":"6","key":"10.1016\/j.vaccine.2017.05.036_b0160","doi-asserted-by":"crossref","first-page":"e11334","DOI":"10.1371\/journal.pone.0011334","article-title":"Outer membrane vesicles derived from Escherichia coli induce systemic inflammatory response syndrome","volume":"5","author":"Park","year":"2010","journal-title":"PLoS One"},{"issue":"38","key":"10.1016\/j.vaccine.2017.05.036_b0165","doi-asserted-by":"crossref","first-page":"25804","DOI":"10.1074\/jbc.M109.022772","article-title":"Secondary acylation of Vibrio cholerae lipopolysaccharide requires phosphorylation of Kdo","volume":"284","author":"Hankins","year":"2009","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.vaccine.2017.05.036_b0170","doi-asserted-by":"crossref","first-page":"e76583","DOI":"10.1371\/journal.pone.0076583","article-title":"Vibrio cholerae porin OmpU inducespro-inflammatory responses, but down-regulates LPS-mediated effects in RAW 264.7,THP-1 and human PBMCs","volume":"8","author":"Sakharwade","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.036_b0175","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0378-1097(03)00562-7","article-title":"Eukaryotic cell signaling and transcriptional activation induced by bacterial porins","volume":"226","author":"Galdiero","year":"2003","journal-title":"FEMS Microbiol Lett"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.036_b0180","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1128\/IAI.72.2.1204-1209.2004","article-title":"Haemophilus influenzae porin induces Toll-like receptor 2-mediated cytokine production in human monocytes and mouse macrophages","volume":"72","author":"Galdiero","year":"2004","journal-title":"Infect Immun."},{"issue":"5","key":"10.1016\/j.vaccine.2017.05.036_b0185","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1038\/cti.2016.22","article-title":"Toll-like receptors the swiss army knife of immunity and vaccine development","volume":"5","author":"Dowling","year":"2016","journal-title":"Clin Transl Immunology"},{"issue":"9","key":"10.1016\/j.vaccine.2017.05.036_b0190","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1038\/jid.2012.111","article-title":"Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients","volume":"132","author":"Dispenza","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"12","key":"10.1016\/j.vaccine.2017.05.036_b0195","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1038\/jid.2008.155","article-title":"All-trans retinoic acid shifts Propionibacterium acnes-induced matrix degradation expression profile toward matrix preservation in human monocytes","volume":"128","author":"Jalian","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.vaccine.2017.05.036_b0200","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/mi.2015.114","article-title":"Oral tolerance is inefficient in neonatal mice due to a physiological vitamin A deficiency","volume":"9","author":"Turfkruyer","year":"2016","journal-title":"Mucosal Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2017.05.036_b0205","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1128\/IAI.00356-12","article-title":"Neutrophils are essential for containment of Vibrio cholerae to the intestine during the proinflammatory phase of infection","volume":"80","author":"Queen","year":"2012","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2017.05.036_b0210","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1128\/IAI.00054-14","article-title":"Vibrio cholerae-induced inflammation in the neonatal mouse cholera model","volume":"82","author":"Bishop","year":"2014","journal-title":"Infect Immun"},{"issue":"343","key":"10.1016\/j.vaccine.2017.05.036_b0215","doi-asserted-by":"crossref","first-page":"d5094","DOI":"10.1136\/bmj.d5094","article-title":"Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5:systematic review and meta-analysis","volume":"25","author":"Mayo-Wilson","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2017.05.036_b0220","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1128\/CMR.18.3.446-464.2005","article-title":"Effects of vitamin a supplementation on immune responses and correlation with clinical outcomes","volume":"18","author":"Villamor","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2017.05.036_b0225","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1189\/jlb.4A1014-498R","article-title":"TLR2, but not TLR4, plays a predominant role in the immune responses to cholera vaccines","volume":"98","author":"Yang","year":"2015","journal-title":"J Leukoc Biol"},{"issue":"4\u20135","key":"10.1016\/j.vaccine.2017.05.036_b0230","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3109\/08820131003622635","article-title":"Secretory IgA arresting microbial pathogens at epithelial borders","volume":"39","author":"Mantis","year":"2010","journal-title":"Immunol Invest"},{"issue":"8","key":"10.1016\/j.vaccine.2017.05.036_b0235","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1741-7007-8-129","article-title":"Immunogenicity and efficacy of oral vaccines in developing countries lessons from a live cholera vaccine","volume":"4","author":"Levine","year":"2010","journal-title":"BMC Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.036_b0240","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1651-2227.2003.tb00522.x","article-title":"Impact of nutritional status on antibody responses to different vaccines in undernourished Gambian children","volume":"92","author":"Moore","year":"2003","journal-title":"Acta Paediatr"},{"issue":"3","key":"10.1016\/j.vaccine.2017.05.036_b0245","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/cei.12238","article-title":"Adjuvant potential of low dose all-trans retinoic acid during oral typhoid vaccination in Zambian men","volume":"175","author":"Lisulo","year":"2014","journal-title":"Clin Exp Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17306606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17306606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T23:04:42Z","timestamp":1569366282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17306606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":49,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0264410X17306606"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.036","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retinoic acid pre-treatment down regulates V. cholerae outer membrane vesicles induced acute inflammation and enhances mucosal immunity","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}